Market Research: Identified & Delivered

Canada Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022




Canada Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022 Summary Publisher’s new report, 'Canada Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022', provides key market data on the Canada Magnetic Resonance Imaging (MRI) Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - 3T MRI Systems and 1.5T MRI Systems. The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size and company share data for Magnetic Resonance Imaging (MRI) Systems market segements - 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems. - Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for each of the market segements. - Global corporate-level profiles of key companies operating within the Canada Magnetic Resonance Imaging (MRI) Systems market. - Key players covered include Siemens Limited, GE Healthcare Limited, Philips Healthcare and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Magnetic Resonance Imaging (MRI) Systems Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 MRI Systems Market, Canada 7
3.1 MRI Systems Market, Canada, Revenue ($m), 2008-2015 7
3.2 MRI Systems Market, Canada, Revenue ($m), 2015-2022 9
3.3 MRI Systems Market, Canada, Volume (Units), 2008-2015 11
3.4 MRI Systems Market, Canada, Volume (Units), 2015-2022 13
3.5 MRI Systems Market, Canada, Average Price ($), 2008-2022 15
3.6 MRI Systems Market, Canada, Distribution Share by Revenue ($m), 2014-2015 16
3.7 MRI Systems Market, Canada, Company Share by Revenue ($m), 2015 17
4 Overview of Key Companies in Canada, MRI Systems Market 19
4.1 Siemens Limited 19
4.1.1 Company Overview 19
4.2 GE Healthcare Ltd 19
4.2.1 Company Overview 19
4.3 Toshiba Medical Systems Corporation 19
4.3.1 Company Overview 19
4.4 Philips Healthcare 20
4.4.1 Company Overview 20
5 MRI Systems Market Pipeline Products 21
6 Financial Deals Landscape 23
6.1 Equity Offerings 23
6.1.1 Profound Medical Raises USD13.2 Million in Public Offering of Shares 23
6.2 Partnerships 24
6.2.1 MagnetTx Oncology Solutions Enters into Licensing Agreement with Alberta Health Services and University of Alberta 24
6.2.2 Profound Medical Enters into Agreement with Siemens Healthcare 26
6.2.3 Terumo Enters into Distribution Agreement with Quirem Medical 27
7 Recent Developments 28
7.1 Corporate Communications 28
7.1.1 May 31, 2016: New Class of Protein Could Treat Cancer and Other Diseases, Georgia State Researchers Find 28
7.1.2 Apr 11, 2016: Aduro Biotech Chief Scientific Officer to Highlight the Potential of STING Activation in Cancer Immunotherapy in a Major Symposium at the 2016 American Association for Cancer Research Annual Meeting 29
7.2 Financial Announcements 30
7.2.1 May 06, 2016: Early diagnosis, a multidisciplinary approach and access to new therapies, key in the treatment of ovarian cancer 30
7.2.2 Apr 12, 2016: Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting 33
7.3 Other Significant Developments 35
7.3.1 Jun 01, 2016: Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management 35
8 Appendix 37
8.1 Research Methodology 38
8.1.1 Coverage 38
8.1.2 Secondary Research 38
8.1.3 Primary Research 39
8.1.4 Market Modeling and Forecasting 40
8.1.5 Company Share Analysis 41
8.1.6 Distribution Share Analysis 42
8.1.7 Benchmarking 42
8.2 Publisher Consulting 42
8.3 Contact Us 43
8.4 Disclaimer 43

Let our analyst help you with a customized solution for your market research needs